Host Defense Versus Immunosuppression: Unisexual Infection With Male or Female Schistosoma mansoni Differentially Impacts the Immune Response Against Invading Cercariae

Infection with the intravascular diecious trematode . remains a serious tropical disease and public health problem in the developing world, affecting over 258 million people worldwide. During chronic infection, complex immune responses to tissue-entrapped parasite eggs provoke granulomatous inflamma...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in immunology Vol. 9; p. 861
Main Authors Sombetzki, Martina, Koslowski, Nicole, Rabes, Anne, Seneberg, Sonja, Winkelmann, Franziska, Fritzsche, Carlos, Loebermann, Micha, Reisinger, Emil C
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 24.04.2018
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Infection with the intravascular diecious trematode . remains a serious tropical disease and public health problem in the developing world, affecting over 258 million people worldwide. During chronic infection, complex immune responses to tissue-entrapped parasite eggs provoke granulomatous inflammation which leads to serious damage of the liver and intestine. The suppression of protective host immune mechanisms by helminths promotes parasite survival and benefits the host by reducing tissue damage. However, immune-suppressive cytokines may reduce vaccine-induced immune responses. By combining a single-sex infection system with a murine air pouch model, we were able to demonstrate that male and female schistosomes play opposing roles in modulating the host's immune response. Female schistosomes suppress early innate immune responses to invading cercariae in the skin and upregulate anergy-associated genes. In contrast, male schistosomes trigger strong innate immune reactions which lead to a reduction in worm and egg burden in the liver. Our data suggest that the female worm is a neglected player in the dampening of the host's immune defense system and is therefore a promising target for new immune modulatory therapies.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Specialty section: This article was submitted to Inflammation, a section of the journal Frontiers in Immunology
Reviewed by: Arnon Dias Jurberg, Fundação Oswaldo Cruz (Fiocruz), Brazil; Ahmad Ali Othman, Tanta University, Egypt
Edited by: Alexandre Mebazaa, Assistance Publique Hopitaux De Paris (AP-HP), France
ISSN:1664-3224
1664-3224
DOI:10.3389/fimmu.2018.00861